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Abstract: The macrophages belong to the effector cells of both nonspecific and specific immune response. These cells generally
express little cytotoxicity unless activated. The present work was intended to determine if peritoneal macrophages collected
from patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) during episodes of peritonitis were active against human
tumor cell lines without further in vitro stimulation. We also compared macrophage antitumor potential with effectiveness of
drugs used in cancer therapy (taxol and suramin). Conditioned medium (CM) of macrophages collected during inflammation-
free periods did not exhibit cytostatic and cytotoxic activity against both tumor (A549 and HTB44) and non-transformed
(BEAS-2B and CRL2190) cells. Exposure of tumor cells to CM of macrophages harvested during peritonitis resulted in
significant suppression of proliferation, impairment of viability and induction of apoptosis, in contrast to non-transformed cells,
which remained unaffected. The efficacy of CM of inflammatory macrophages as an antitumor agent appeared to be comparable
to cytostatic and cytotoxic potency of taxol and suramin or, in the case of HTB44 cells, even higher. The results obtained
suggest that activated human macrophages might represent a useful tool for cancer immunotherapy.
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Introduction
Over the past decade much research has been focused
on the role of immune system in malignant disease.
Although much has been learned about tumor antige-
nicity, cytokine activity and specific immune cell types,
the understanding of how malignancy and the immune
system interrelate is still a mystery [2]. The macro-
phages belong to the effector cells of both nonspecific
and specific immune response. These cells generally
express little cytotoxicity unless activated [8]. Activa-
tion is a complex biological process which culminates
in the formation of cells with the ability to mediate tumor
cell killing, directly as a result of cell-to-cell contact or
indirectly through the secretion of cytotoxic and cytos-
tatic products [8, 24]. 
Peritoneal fluid obtained from patients in end-stage
renal disease undergoing Continuous Ambulatory Peri-
toneal Dialysis (CAPD) provides a readily accessible
source for human macrophages. These cells can be
collected when CAPD is performed without complica-
tions or during an intercurrent peritonitis. This renders
it possible to study antitumor potential of human mac-
rophages as related to their presence in a non-inflamma-
tory or inflammatory environment. Peritoneal
macrophages from patients on CAPD represent a popu-
lation of fully functional cells [4]. It has been reported
that these cells can be induced to express antitumor
activity against tumor cells, especially if collected dur-
ing a period of peritonitis [5].
The present work was intended to determine if peri-
toneal macrophages collected from patients on CAPD
during episodes of inflammation were active against
human tumor cell lines without additional in vitro stimu-
lation. The macrophages were isolated from peritoneal
effluents during both inflammation-free periods and epi-
sodes of peritonitis. In this report we describe the in-
fluence of macrophage-conditioned medium (CM) on
growth and survival of two types of human tumor cell
lines: A549 (lung carcinoma) and HTB44 (renal carci-
noma) in comparison with non-transformed cell lines:
BEAS-2B (bronchial epithelium cells) and CRL2190
(renal proximal tubular cells). 
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The purpose of the present study was also to compare
antitumor potential of macrophages with the effective-
ness of cytostatics used in the therapy of lung and kidney
tumors (taxol and suramin, respectively). 
Materials and methods 
Chemicals. Dulbecco’s Modified Eagle’s Medium (DMEM), Mini-
mal Essential Medium (MEM), F12 medium, bovine serum albumin,
non-essential amino acids, insulin, hydrocortisone, 3,3’,5-triiodo-
thyronine, transferrin, taxol, suramin, Hoechst No 33258, Giemsa
dye and kit for non-specific esterase were purchased from Sigma (St.
Louis, US). Keratinocyte-Serum Free Medium (Keratinocyte-SFM),
calf serum, recombinant epidermal growth factor (rEGF) and bovine
pituitary extract were purchased from Gibco (San Diego, US). The
other reagents were provided by POCh (Gliwice, Poland).
Macrophage isolation and culture. Human macrophages were
harvested from peritoneal dialysate effluents (PDEs) of patients in
end-stage renal disease undergoing CAPD treatment. PDEs were
collected during both inflammation-free periods and episodes of
peritonitis. Non-infective PDEs from 2-3 patients were pooled be-
cause of difficulties in obtaining appropriate number of cells from
one individual. A total cell population increased markedly during
peritonitis and sufficient numbers of cells were isolated from PDEs
of individual patients. Complete dialysate effluent volume was cen-
trifuged at 1500 rpm for 10 min at 4˚C. The cell pellet was washed
with 0.9% NaCl and centrifuged again at 1500 rpm for 10 min. After
suspension in DMEM supplemented with 10% calf serum, the cells
were counted and their viability assessed by trypan blue exclusion
test. The purity of isolated cells was determined by non-specific
esterase [10] and May Grünwald-Giemsa [25] staining. The viability
of the cells exceeded 90%. The average percentages of macrophages
in non-inflammatory and inflammatory PDEs were 50-60% and 20%
of the total cell number, respectively. The cell density was adjusted
to 4x106/ml of DMEM with 10% calf serum, placed in plastic dishes
at total volume of 5 ml and incubated for 2 h at 37˚C. The medium
with non-adherent cells was then discarded and the dishes were
washed twice to remove residual non-adherent cells. Approximately
90% of adherent cells were macrophages. The macrophages were
cultured for 24 h in serum-free DMEM/F12 (1:1) medium sup-
plemented with transferrin (5 µg/ml) and selenate (2 ng/ml).
Conditioned medium (CM) preparation. CM of peritoneal mac-
rophages was collected following 24 h of culture, centrifuged at 1500
rpm for 10 min and concentrated by ultrafiltration through Millipore
membrane of 3000 NMWL (nominal molecular weight limit). Con-
centration of proteins in CM was determined by Lowry’s method
[15].
Target cells. The human tumour cell lines A549 (lung carcinoma)
and HTB44 (renal carcinoma) as well as human normal cell lines
BEAS-2B (bronchial epithelium cells) and CRL2190 (proximal tu-
bular cells) were used as target cells. BEAS-2B and CRL2190 cells
served as a control of CM action selectivity. A549 cells were cultured
in DMEM with 10% calf serum, HTB44 cells in MEM supplemented
with non-essential amino acids, sodium pyruvate and 10% calf
serum, BEAS-2B cells in F12 medium supplemented with rEGF,
insulin, hydrocortisone, 3,3’,5-triiodothyronine, transferrin and 5%
calf serum and CRL2190 in Keratinocyte-SFM with rEGF, bovine
pituitary extract and 10% calf serum. All cell lines were purchased
from American Type Culture Collection (Manassas, US). 
Cytostatic and cytotoxic activity assays. Target cells were seeded
on 96-well plates at concentrations of 1×104 cells/well (A549,
HTB44 and BEAS-2B) or 5×103 cells/well (CRL2190) in specific
culture media (described above) with calf serum. Following 24 h of
incubation the media were removed and replaced with 200 µl/well
of serum-free media containing 20 µg or 40 µg of macrophage CM
proteins. The incubation was continued for the next 48 h at 37˚C.
Target cells incubated with media alone served as a control. The
modified crystal violet staining method [10] and Bürker chamber
counting method served as a measure of cytostasis by macrophage
supernatants. The MTT tetrazolium assay [18] and neutral red assay
[7] were used to determine the influence of supernatants on target
cell viability. The cytostatic activity of macrophage CM against
target cells and the effect on their viability were determined in
comparison with control and expressed as percentages of control
growth and control values, respectively. The antitumor activity of
macrophage CM was also compared with the influence of taxol and
suramin on transformed cell proliferation and viability. To this end
A549 and HTB44 cells were incubated for 48 h with media sup-
plemented with 50 nm taxol or 1 mM suramin.
CM of peritoneal macrophages were also tested for ability to
induce tumour cell apoptosis. A549 and HTB44 cells suspended in
specific culture media supplemented with serum were seeded at glass
slides placed in the 6-well plates at a concentration of 4×104
cells/well. After 24 h of culture, media were replaced with 1 ml/well
of media without serum containing 200 µg of macrophage CM
proteins. Following 48 h of incubation, cells were fixed in the mixture
of methanol and acetic acid (Carnoy fixative) or 1% formaldehyde
and stained with Giemsa dye or Hoechst No 33258 dye. Observations
were carried out with Olympus IX inverted system microscope. The
ability of CM to induce nuclear alterations was compared with the
effect of taxol (50 nM) and suramin (1 mM). 
Statistics. The data was expressed as mean ± SD, analysed using
Student’s t-test and considered significant at p<0.005.
Results
Peritoneal cells
Dialysis effluents from patients without inflammation
allowed to obtain approximately 5-10×106 peritoneal
cells from 2-3 L of fluid. During peritonitis, the number
of cells increased markedly and 0.1-5×109 cells were
collected from effluent of one patient. The viability of
isolated cells exceeded 90%, as assessed by trypan blue
exclusion test. The average percentage of macrophages
in non-inflammatory PDEs was 50-60% of total cell
number and decreased to 20% in inflammatory effluents,
as evaluated by May Grünwald-Giemsa and non-spe-
cific esterase staining. The number of neutrophils in-
creased significantly during the inflammatory state and
their contribution to the total cell population could ex-
ceed even 90% at the beginning of peritonitis. Ability of
macrophages to adhere to plastic dishes within 2 h
allowed to obtain 90% pure cultures of these cells. 
Effect of CM on target cell proliferation
Transformed (A549, HTB44) and non-transformed
(BEAS-2B, CRL2190) cells were exposed for 48 h to
conditioned media of macrophages collected during
both non-inflammatory and inflammatory states, added
at two different concentrations: 20 µg and 40 µg of
proteins/well. Numbers of investigated cells determined
by crystal violet staining and Bürker chamber counting
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methods are shown in Table 1. The influence of CM on
the cell growth was expressed as relative (to control)
increase in cell number (Ri) after 48 h of incubation with
CM and calculated as follows:
% Ri = (CM20/40 - Ko)/ (K48 - Ko) × 100%
where CM20/40 = numbers of cells after 48 h of incu-
bation with 20 µg or 40 µg of CM proteins; K0, K48 =
numbers of cells in control at the start of experiment and
after 48 h, respectively. Average Ri values are presented
in Figure 1. 
CM of macrophages collected during inflammation-
free periods did not exhibit cytostatic activity against
either transformed or non-transformed cells. Exposure
of tumor cells to CM of macrophages harvested during
peritonitis resulted in significant suppression of prolife-
ration compared to control (Ri for A549 cells incubated
with 20 µg and 40 µg of CM proteins were 69% and
31%, respectively and for HTB44 cells 49% and 2%,
respectively). In contrast to tumor cells, the growth of
non-transformed cells was not inhibited. The results
indicated that macrophages activated during peritonitis
produced substances with strong cytostatic activity, they
also suggested that kidney tumor cells (HTB44) were
much more susceptible to the action of these agents than
lung tumor cells (A549).
The ability of inflammatory CM to suppress tumor
cell growth was compared to cytostatic activity of taxol
and suramin. This comparison is shown in Figure 2.
Percentage inhibitions of growth of A549 cells exposed
to inflammatory CM (200 µg of proteins/ml), taxol (50
nM) and suramin (1 mM) were 69%, 83% and 68%,
respectively. Exposure of HTB44 cells to these substan-
ces resulted in 98%, 79% and 63% of growth inhibition,
respectively. These results showed that the highest cy-
tostatic activity against A549 cells was exhibited by
taxol, while inflammatory CM suppressed the growth of
lung tumor cells to the same extent as suramin. Inflam-
matory CM appeared, however, to be the most effective
against HTB44 cells. 
Effect of CM on target cell viability 
The influence of CM on target cell viability was assessed
by MTT tetrazolium and neutral red staining methods
and expressed as average percentages of control values
after 48 h of incubation with CM. The results are shown
in Figure 3. Non-inflammatory CM had no appreciable
effect on viability of both transformed and non-trans-
formed cells. CM of macrophages collected during peri-
tonitis impaired the viability of tumor cells, in contrast
to non-transformed cell, which were unaffected. The
values of absorbance obtained for A549 and HTB44
cells after 48 h of incubation with the maximal used
concentration of CM proteins were 76% and 21% of the
control, respectively. The results indicated that during
peritonitis macrophages acquired ability to release cyto-
toxic substances and that HTB44 cells were more sus-
ceptible to them than A549 cells. Figure 4 shows the
comparison of inflammatory CM (200 µg of pro-
Table 1. Effect of conditioned medium (CM) of peritoneal macrophages obtained from patients in non-inflammatory (NI) and inflammatory
(I) periods on proliferation of transformed (A549, HTB44) and non-transformed (BEAS-2B, CRL2190) cell lines
NI I NI I
CV BC CV BC CV BC CV BC
A549×103 BEAS-2B×103
K0 9.7±2.0 9.8±2.6 9.7±2.0 9.8±2.6 8.0±0.9 9.5±0.9 8.0±0.9 9.5±0.9
K48 31.7±3.9 37.6±4.4 31.7±3.9 37.6±4.4 16.8±2.3 24.0±2.6 16.8±2.3 24.0±2.6
CM20 31.4±3.4 38.1±3.0 25.1±1.7* 28.5±3.6* 17.0±2.1 23.5±2.0 17.1±1.8 22.5±1.5
CM40 30.5±1.0 41.1±3.5 17.9±1.7* 16.8±3.1* 17.3±2.1 24.7±3.7 16.7±1.3 25.4±2.8
HTB44×103 CRL2190×103
K0 7.5±1.1 8.4±1.8 7.5±1.1 8.4±1.8 3.3±0.1 3.4±0.7 3.3±0.1 3.4±0.7
K48 20.4±0.9 19.4±0.8 20.4±0.9 19.4±0.8 6.9±0.8 7.3±0.5 6.9±0.8 7.3±0.5
CM20 19.6±0.3 19.0±0.2 14.4±1.3* 13.3±0.7* 6.8±0.1 7.4±0.7 7.2±0.2 7.2±0.9
CM40 19.3±0.9 18.2±0.2 7.8±0.5* 8.6±0.7* 6.4±0.1 7.6±0.4 6.6±0.5 7.4±1.0
CV - numbers of cells determined by crystal violet staining method; BC - numbers of cells evaluated by Bürker chamber counting
method; K0, K48 - numbers of cells in control at the start of experiment and after 48 h, respectively; CM20/40 - numbers of cells after 48 h
of incubation with 20 µg or 40 µg of CM proteins; * - values significantly different from control.
Experiments were repeated six times with similar results (means ± SD are presented); the SD values  between three parallel samples with-
in the same experiments were less than ±  1%.
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teins/ml), taxol (50 nM) and suramin (1 mM) influence
on investigated tumor cell viability. The percentages of
control values obtained for A549 cells incubated with
CM, taxol and suramin were 76%, 64% and 70%, re-
spectively and for HTB44 cells 21%, 56% and 37%,
respectively. The results suggested that taxol was the
most effective in impairing A549 cell viability, while
CM influenced HTB44 cell viability more than the other
two compounds. 
Induction of apoptosis
CM of peritonitis-harvested macrophages was also
examined for their cytotoxic potential, especially ability
to induce tumor cell apoptosis. Apoptotic cells were
clearly distinguishable by characteristic morphology
(cytoplasmic blebbing, cell shrinkage, nuclear conden-
sation and fragmentation). Such morphological alter-
ations were found in both A549 and HTB44 cells
incubated with inflammatory CM (200 µg of pro-
teins/ml) and 50 nM taxol but not with 1 mM suramin.
The results obtained for HTB44 cells are presented in
Figure 5. Similar effects were observed in the case of
A549 cells (data not shown). 
Discussion
It has been reported that human peritoneal macrophages
collected from renal patients on CAPD can be induced
to express antitumor activity against tumor cells, espe-
cially if they were obtained during periods of peritonitis
and if further stimulated in vitro by LPS [5]. The ability
of LPS to induce antitumor activity in human peritoneal
macrophages harvested during peritonitis was assumed
to be due to the stimulation of the macrophages already
"primed" in vivo in an inflammatory environment [4, 5].
It has been also shown that peritoneal macrophages
collected from patients on CAPD during inflammation-
free periods can be stimulated in vitro to express antitu-
mor activity [4]. The aim of the present study was to
determine whether macrophages obtained from patients
with peritonitis were active against human tumor cells
without additional in vitro stimulation and, if they were,
to compare this activity with efficacy of the compounds
used in cancer therapy (taxol and suramin). The target
models chosen were of human tumor cell lines isolated
from the cases of lung and renal carcinoma. These
models had the advantage of using cells originating from
the kinds of tumors which are treated in cancer therapy
with taxol and suramin 
We showed first that CM of macrophages collected
during peritonitis was active against tumor cells, in
Fig. 1. The effect of peritoneal mac-
rophage CM on target cell prolifera-
tion. Following 48 h of incubation of
target cells with  peritoneal macro-
phage CM their numbers were deter-
mined by Bürker chamber counting
and crystal violet staining methods.
The results are presented as a relative
(to control) increase in cell number
(Ri) after 48 h of incubation with
CM. The values are the means  ± SD
of six separate experiments. NI CM
- non-inflammatory conditioned me-
dium; I CM - inflammatory condi-
tioned medium; * - values signifi-
cantly different from control. 
Fig. 2. The comparison of cytostatic activity of inflammatory CM,
taxol and suramin against A549 and HTB44 cell lines. After 48 h of
incubation of tumor cells with inflammatory CM (200 µg of pro-
teins/ml), taxol (50 nM) and suramin (1 mM), their numbers were
assessed by Bürker chamber counting and crystal violet staining
methods. The values are the means ± SD of six separate experiments.
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contrast to CM of macrophages harvested during inflam-
matory-free periods, which did not influence the growth
and viability of transformed cells. We did not notice the
effect of macrophage CM on the proliferation and sur-
vival of non-transformed cells, what confirmed selec-
tive, only antitumor cell-directed activity of the evaluated
supernatants. These results suggested that macrophages
obtained from patients with peritonitis represented a
population of fully activated rather than only "primed"
cells. During inflammatory state, the macrophages ac-
quired the capability to cytostatic and cytotoxic action
and did not require further in vitro stimulation in order to
express a potent antitumor activity. 
The antitumor activity of macrophages collected dur-
ing peritonitis comprised the inhibition of target cell
growth, impairment of cell viability and induction of
apoptosis. Inflammatory CM exerted a potent cytostatic
effect on both evaluated tumor cell lines. A significant
suppression of growth was seen for HTB44 cells. The
number of cells following 48 h of incubation with the
highest used concentration of CM proteins was only 2%
of control growth. Also the proliferation of A549 cells
was inhibited as a result of exposition to inflammatory
CM (31% of control growth). The impairment of cell
viability was particularly seen in the case of HTB44 cells
(only 21% of control values after 48 h of incubation with
the maximal used concentration of CM proteins). A
weaker but statistically significant effect was noticed for
A549 cells (76% of control). Both examined tumor cell
lines proved to be susceptible to agents triggering apop-
tosis present in CM of activated macrophages. 
The results of the present study indicate that suscep-
tibility of A549 and HTB44 cells to CM of inflammatory
macrophages is different. The cells of kidney tumor
were much more sensitive to CM than cells of lung
tumor. Further studies are necessary to determine the
agents and mechanisms underlying this difference. 
The cytostasis caused by macrophage CM was medi-
ated probably by TNFα and/or IL-1β [3, 6, 13]. The
effect of macrophage anti-proliferative activity appears
to be directed on the process of DNA synthesis. Many
studies have employed the incorporation of [3H]thy-
midine into DNA during a period following or concomi-
tant with exposure to cytostatic macrophages and they
have clearly demonstrated that the utilization of nucleo-
tide precursors for macromolecular synthesis is de-
creased by co-culture of target cells with macrophages
or incubation with macrophage secretory products, re-
sulting in a reduced DNA content [6, 11]. The cytotoxic
effect of activated macrophages is primarily mediated
by nitric oxide due to its ability to inhibit mitochondrial
respiration and denature various essential iron-sulphur-
Fig. 3. The influence of peritoneal
macrophage CM on target cell via-
bility. Following 48 h of incubation
of target cells with  peritoneal mac-
rophage CM, the values of absorb-
ance of MTT tetrazolium and neutral
red were assessed. Data shown rep-
resent the means ± SD of six separate
experiments. NI CM - non-inflam-
matory conditioned medium; I CM -
inflammatory conditioned medium;
* - values significantly different
from control.
Fig. 4. The comparison of inflammatory CM, taxol and suramin
effects on A549 and HTB44 cell viability. After 48 h of incubation
of tumor cells with inflammatory CM (200 µg of proteins/ml), taxol
(50 nM) and suramin (1 mM), the values of absorbance of MTT
tetrazolium and neutral red were assessed. Data shown represent the
means ± SD of six separate experiments . 
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containing enzymes present in target cells [16]. Other
antitumor products secreted by macrophages include
TNFα, reactive oxygen and nitrogen intermediates and
FasL (CD95L), which are equally essential for macro-
phage cytotoxicity [13, 17]. In our experimental model
in which tumor cells were exposed not to macrophages
but to the macrophage-conditioned medium, the partici-
pation of reactive oxygen and nitrogen species should
be excluded because of the lability of these compounds.
In the present study, we also focused on the compari-
son of macrophage antitumor activity with the anti-mi-
totic and cytotoxic potential of taxol and suramin. We
demonstrated that the most effective in suppressing
A549 cells growth was taxol (83% inhibition of prolife-
ration), whereas inflammatory CM inhibited growth of
these cells to almost the same extent as suramin (about
69% of growth inhibition). The greatest cytostatic effect
in the case of HTB44 cells was noted for inflammatory
CM (98% of growth inhibition), while taxol and suramin
suppressed proliferation of these cells to a lesser extent.
In our comparative study, taxol appeared to be more
effective than inflammatory CM in impairment of A549
cells viability, whereas the latter was the most powerful
in affecting HTB44 cells. We also found that among
three compounds examined in this study only suramin
did not trigger apoptosis. 
The mechanism of cytostatic and cytotoxic activity
of taxol and suramin is different from that of macro-
phage CM described above. Anti-mitotic action of taxol
is due to its ability to bind to microtubules of the ka-
ryokinetic spindle. This makes the process of microtu-
bule depolymerization, necessary for nucleus division,
impossible [22, 23]. Taxol can trigger the apoptosis
through induction of some transcription factors and
enzymes modulating the process of programmed cell
death and through interaction with proteins of Bcl-2
family [19]. Suramin influences the process of DNA
synthesis through inhibition of DNA polymerase syn-
thesis or activity and through precluding the formation
of DNA-topoisomerase II complex [14]. Suramin has
also ability to suppress some cyclin-dependent kinases
[9]. This substance has also capability to inhibit the ATP
synthesis, disturb mitochondrial electron transport chain
and to impair in this way cell viability [21]. 
Fig. 5. Photomicrographs of HTB44 cells incubated for 48 h: A - in the medium alone; B - in the presence of inflammatory CM (200 µg of
proteins/ml); C - in the presence of taxol (50 nM); D - in the presence of suramin (1 mM). Apoptotic cells can be seen in B and C. The cells
were fixed with Carnoy fixative and stained with Giemsa solution. × 400. 
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The macrophages seem to be useful for adoptive
cellular immunotherapy, based on retrieving patient’s
own mononuclear cells, activating them in vitro and then
infusing them back into the patient [1, 12]. The study of
ovarian cancer patients, to whom γ-interferon was ad-
ministrated intraperitoneally, revealed a 32% response
rate and a 23% complete response rate, defined as "the
disappearance of all macroscopic and microscopic dis-
ease with negative histology". The authors attributed
these encouraging findings to the effect of γ-interferon
on peritoneal macrophage function [20]. Our results also
confirmed the theory that macrophages can represent a
useful tool in cancer immunotherapy.
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